Anti-SHARP2/DEC1 antibody [EPR23905-116]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
- WB
Lab
Western blot - Anti-SHARP2/DEC1 antibody [EPR23905-116] (AB259837)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Exposure time : 125 seconds
All lanes:
Western blot - Anti-SHARP2/DEC1 antibody [EPR23905-116] (ab259837) at 1/1000 dilution
Lane 1:
MCF7 (human breast adenocarcinoma epithelial cell) cytoplasmic fraction at 20 µg
Lane 2:
MCF7 (human breast adenocarcinoma epithelial cell) nuclear fraction at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 46 kDa
false
- WB
Lab
Western blot - Anti-SHARP2/DEC1 antibody [EPR23905-116] (AB259837)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Exposure time : 3 minutes
All lanes:
Western blot - Anti-SHARP2/DEC1 antibody [EPR23905-116] (ab259837) at 1/1000 dilution
Lane 1:
HeLa (human epithelial cell line from cervix adenocarcinoma), whole cell lysate at 20 µg
Lane 2:
293T (human embryonic kidney epithelial cell), whole cell lysate at 20 µg
Lane 3:
MDA-MB-231 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 4:
T47D (human ductal breast epithelial tumor epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 46 kDa
false
Related conjugates and formulations (1)
-
Anti-SHARP2/DEC1 antibody [EPR23905-116] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This transcription factor plays a significant role in the regulation of circadian rhythms and cell cycle progression. SHARP2/DEC1 interacts with various proteins to form complexes that influence cell differentiation and proliferation showing its critical function in maintaining cellular homeostasis. The protein also participates in hypoxia response being upregulated under low oxygen conditions which points to its adaptability and function under stress.
Pathways
SHARP2/DEC1 is an important component of the circadian clock and hypoxia signaling pathways. It modulates the activity of other clock genes and interacts with the PER and CRY protein families adding precision to circadian regulation. In the hypoxia pathway SHARP2/DEC1 activity affects the expression of genes involved in cellular adaptation to low oxygen levels cooperating with hypoxia-inducible factors to maintain balance during such conditions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Publications (1)
Recent publications for all applications. Explore the full listand refine your search
Hereditas 162:87 PubMed40413527
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com